Convalescent plasma treatment for patients of 80 years and older with COVID-19 pneumonia

BACKGROUND: Older patients, frequently with multiple comorbidities, have a high mortality from COVID-19 infection. Convalescent plasma (CP) is a therapeutic option for these patients. Our objective is to retrospectively evaluate the efficacy and adverse events of CP treatment in this population grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Romon, Iñigo, Dominguez-Garcia, Juan J., Arroyo, Jose L., Suberviola, Borja, Cabezón, Itxasne, Abascal, Beatriz, Baldeón, Cristina, Cuesta, Amalia, Portilla, Raquel, Casuso, Elena, Ocio, Enrique, Briz, Montserrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521266/
https://www.ncbi.nlm.nih.gov/pubmed/34663227
http://dx.doi.org/10.1186/s12877-021-02447-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521266/
https://www.ncbi.nlm.nih.gov/pubmed/34663227
http://dx.doi.org/10.1186/s12877-021-02447-9

Ejemplares similares